These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28833217)

  • 21. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
    Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
    Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
    Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients.
    Chen MM; Roman SA; Sosa JA; Judson BL
    JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):137-41. PubMed ID: 25474617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment, comorbidity and survival in stage III laryngeal cancer.
    Connor KL; Pattle S; Kerr GR; Junor E
    Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
    Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
    Rao YJ; Chin RI; Hui C; Mutch DG; Powell MA; Schwarz JK; Grigsby PW; Markovina S
    Gynecol Oncol; 2017 Sep; 146(3):572-579. PubMed ID: 28662775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
    Korpics MC; Block AM; Martin B; Hentz C; Gaynor ER; Henry E; Harkenrider MM; Solanki AA
    Cancer; 2017 Sep; 123(18):3524-3531. PubMed ID: 28581675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Ho AS; Zumsteg ZS
    Head Neck; 2018 Jun; 40(6):1228-1236. PubMed ID: 29417700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
    Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
    Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
    Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
    Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
    Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
    Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
    Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.
    Cheraghlou S; Schettino A; Zogg CK; Otremba MD; Bhatia A; Park HS; Osborn HA; Mehra S; Yarbrough WG; Judson BL
    Laryngoscope; 2019 Apr; 129(4):883-889. PubMed ID: 30151947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.
    Zumsteg ZS; Luu M; Kim S; Tighiouart M; Mita A; Scher KS; Lu DJ; Shiao SL; Mallen-St Clair J; Ho AS
    Ann Oncol; 2019 Jan; 30(1):76-84. PubMed ID: 30395159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
    Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
    Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of chemoradiation for head and neck cancer in an older patient population.
    VanderWalde NA; Meyer AM; Deal AM; Layton JB; Liu H; Carpenter WR; Weissler MC; Hayes DN; Fleming ME; Chera BS
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):30-7. PubMed ID: 24725687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
    Tasoulas J; Lenze NR; Farquhar D; P Schrank T; Shen C; Shazib MA; Singer B; Patel S; Grilley Olson JE; Hayes DN; Gulley ML; Chera BS; Hackman T; Olshan AF; Weiss J; Sheth S
    Cancer Med; 2021 May; 10(10):3231-3239. PubMed ID: 33934525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
    Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.